Developing next-generation immunotherapeutic viruses to help patients defeat cancer

At the cutting edge of oncolytic viral immunotherapy

Vaxalto’s innovative, multimodal platform harnesses the power of direct tumor destruction and immune system activation for complete tumor eradication. Our breakthrough technology boasts high efficacy and safety and has yielded unprecedented pre-clinical results.

APMV
oncolytic virus

Powerful
immunomodulator

System-wide
tumor eradication